Bio of our Founder and CEO, Jashin J. Wu, M.D., F.A.A.D.:
Through the 7 year Honors Program in Medical Education, Jashin J. Wu, M.D., earned a BA in biological sciences from Northwestern University in Evanston, Illinois and an MD from Northwestern University Medical School in Chicago. Dr. Wu completed dermatology residency at the University of California, Irvine, California, where he was chief resident.
Jashin J. Wu, M.D., is Founder and Course Director of the Skin Cancer Symposium® (April 7-8, 2021), Symposium for Inflammatory Skin Disease® (April 9-11, 2021), 2nd Annual San Diego Dermatology Symposium® (June 11-13, 2021), and Dermatology Refresher Symposium™ (October 1-3, 2021), and Founder and CEO of the Dermatology Research and Education Foundation™. He is a Councilor for the International Psoriasis Council. He serves on the American Academy of Dermatology (AAD)/ National Psoriasis Foundation psoriasis guidelines committee, which published updated 6 psoriasis guidelines in 2019-2020. He is editor or co-editor for 6 books which include Therapy for Severe Psoriasis, 1st edition, 2016; Clinical Cases in Psoriasis, 1st edition; Mild-To-Moderate Psoriasis, 3rd edition, 2014; Moderate-To-Severe Psoriasis, 4th edition, 2014. He is associate editor for the 4th edition of Comprehensive Dermatologic Drug Therapy published in March 2020. He has written over 350 Pubmed articles, of which over 250 are about psoriasis, as well as 67 book chapters. His articles have been published in The New England Journal of Medicine, The Lancet, JAMA, Journal of the American Academy of Dermatology, JAMA Dermatology, British Journal of Dermatology, JEADV, and most dermatology journals. For the AAD, he is Chair of the Learning Resources Committee and Deputy Chair of World Congress Fund Review Task Force. He is a Board Member of the Pacific Dermatology Association. Dr. Wu has given over 150 CME psoriasis lectures at medical conferences and dermatology departments/divisions in 11 countries. He has been awarded 2 Presidential Citations from the AAD (2016, 2021).